One-Time Intravitreal Injection of KVD001, a Plasma Kallikrein Inhibitor, in Patients with Central-Involved Diabetic Macular Edema and Reduced Vision: An Open-Label Phase 1B Study

Autor: Sun, Jennifer K., Maturi, Raj K., Boyer, David S., Wells, John A., Gonzalez, Victor H., Tansley, Robert, Hernandez, Helen, Maetzel, Andreas, Feener, Edward P., Aiello, Lloyd Paul
Zdroj: In Ophthalmology Retina December 2019 3(12):1107-1109
Databáze: ScienceDirect